Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG

(EUZ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

ECKERT & ZIEGLER : Buy rating from Hauck & Aufhauser

06/10/2021 | 04:27am EDT

In a research note, Hauck & Aufhauser analyst Aliaksandr Halitsa has maintained his recommendation on the stock with a Buy rating. The target price is unchanged and still at EUR 120.50.


ę MarketScreener with dpa-AFX Analyser 2021
All news about ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
06/15ECKERT & ZIEGLERá : DZ Bank gives a Sell rating
MD
06/10ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Hauck & Aufhäuser
PU
06/10ECKERT & ZIEGLERá : Buy rating from Hauck & Aufhauser
MD
06/08ECKERT & ZIEGLER : Affiliates Receives Additional NIAID Funding to Advance Pharm..
PU
06/08PRESS RELEASE : Eckert & Ziegler: Affiliates Receives Additional NIAID Funding t..
DJ
06/08ECKERT & ZIEGLER : Affiliates Receives Additional NIAID Funding to Advance Pharm..
EQ
06/03ECKERT & ZIEGLER STRAHLEN UND MEDIZI : Telix and Eckert & Ziegler Sign US Co-Pro..
AQ
06/03ECKERT & ZIEGLER STRAHLEN UND MEDIZI : & Ziegler and Telix Pharmaceuticals Enter..
PU
06/03PRESS RELEASE : Eckert & Ziegler and Telix Pharmaceuticals Enter Co-Promotion Ag..
DJ
06/03ECKERT & ZIEGLER STRAHLEN UND MEDIZI : & Ziegler and Telix Pharmaceuticals Enter..
EQ
More news
Financials
Sales 2021 184 M 218 M 218 M
Net income 2021 26,9 M 31,9 M 31,9 M
Net cash 2021 96,9 M 115 M 115 M
P/E ratio 2021 70,0x
Yield 2021 0,48%
Capitalization 1 888 M 2 238 M 2 239 M
EV / Sales 2021 9,76x
EV / Sales 2022 7,82x
Nbr of Employees 843
Free-Float 66,3%
Chart ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Duration : Period :
Eckert & Ziegler Strahlen- und Medizintechnik AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 120,50 €
Last Close Price 91,70 €
Spread / Highest target 31,4%
Spread / Average Target 31,4%
Spread / Lowest Target 31,4%
EPS Revisions
Managers and Directors
NameTitle
Andreas Eckert Chairman-Executive Board
Wolfgang Maennig Chairman-Supervisory Board
Helmut Grothe Vice Chairman-Supervisory Board
Albert Rupprecht Member-Supervisory Board
Edgar L÷ffler Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG104.50%2 238
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795